azathioprine has been researched along with Cancer of Sigmoid in 1 studies
Azathioprine: An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed)
azathioprine : A thiopurine that is 6-mercaptopurine in which the mercapto hydrogen is replaced by a 1-methyl-4-nitroimidazol-5-yl group. It is a prodrug for mercaptopurine and is used as an immunosuppressant, prescribed for the treatment of inflammatory conditions and after organ transplantation and also for treatment of Crohn's didease and MS.
Excerpt | Relevance | Reference |
---|---|---|
"Azathioprine was withdrawn." | 1.40 | Hodgkin's lymphoma rectosigmoid in a patient with ulcerative colitis on long-term azathioprine therapy. ( Khuroo, MS, 2014) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Khuroo, MS | 1 |
1 other study available for azathioprine and Cancer of Sigmoid
Article | Year |
---|---|
Hodgkin's lymphoma rectosigmoid in a patient with ulcerative colitis on long-term azathioprine therapy.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Azathioprine; Colitis, Ulcerative; Hodgkin Dis | 2014 |